ND
ENDRA Life Sciences Inc.
NDRA · NASDAQ
$5.91 -0.42% (-$0.02)
1M +33.11%
Market Cap $7.50M
P/E Ratio -
Div. Yield -
ROE 224.80%
Bulios Fair Price
$5.69
3.6% downside
Trenutna cena
$5.91
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price se delnica NDRA trenutno trguje blizu svoje poštene vrednosti. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/B 1.19x
P/FCF N/A
P/FFO N/A
Growth
0 /100
Declining Book val. growth 32.05%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A FCF margin N/A
Op. margin N/A
Gross margin N/A
Quality
0 /100
Poor Asset turnover 0.00x
ROA 74.50%
ROIC 91.16%
Debt
100 /100
Low Current ratio 7.10x
Debt/Equity 0.07x
Net debt/EBITDA N/A
Stability
35 /100
Moderate EPS volatility 50.47%
Profitable years 0
Beta -0.07x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o NDRA
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Alexander Y. Tokman
Employees
10
Headquarters
Ann Arbor
Prihajajoči dogodki
13 NOV.
Earnings
Upcoming earnings report